...
机译:用先发制人直接代理抗病毒治疗评价供体HCV阳性的早期同种异体移植功能的评价
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
Massachusetts Gen Hosp Liver Ctr Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
Massachusetts Gen Hosp Liver Ctr Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiothorac Surg Div Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiothorac Surg Div Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
Massachusetts Gen Hosp Liver Ctr Boston MA 02114 USA;
Massachusetts Gen Hosp Cardiol Div Boston MA 02114 USA;
机译:用先发制人直接代理抗病毒治疗评价供体HCV阳性的早期同种异体移植功能的评价
机译:当在直接作用抗病毒剂时代将HCV阳性肾脏移植到未染色的接受者时,丙型肝炎病毒阳性不应包含在肾脏供体概况指数计算中
机译:Re:丙型肝炎的成本效益C阳性供体肾移植肝炎患者C阴性受体,伴随直接抗病毒性治疗编辑评论
机译:人心脏移植受者同种异体冠状动脉疾病的前瞻性冠状动脉造影评估
机译:使用泵参数,解剖学性质和供体接受者特征预测移植后肾功能
机译:通过先发抗病毒治疗将HCV阳性肝脏移植到HCV阴性患者中:模型研究
机译:将肾脏从丙型肝炎的肾脏移植到丙型肝炎病毒感染者中,然后早期开始直接作用抗病毒治疗:单中心回顾性研究